Content Type: Article

  • EU Marketing Update: Dutch Regulator Will Require Non-EU Managers To Submit Annex IV Reports From April 2023

    EU Marketing Update: Dutch Regulator Will Require Non-EU Managers To Submit Annex IV Reports From April 2023

    ARTICLE / CLIENT ALERT

    EU Marketing Update: Dutch Regulator Will Require Non-EU Managers To Submit Annex IV Reports From April 2023

    January 5, 2023

    Read time: 2 min

    Key takeaways
    Overview

    Non-EU fund managers that have notified their funds for marketing under the national private placement regime in the Netherlands have until now been exempt from Annex IV reporting obligations to the Autoriteit Financiële Markten (“AFM”). The AFM will now require Annex IV reporting via its online reporting portal. The first reports must be submitted by the end of April 2023.

    Reporting must be submitted in XML format via the AFM Portal. Affected fund managers should consider creating a login account as soon as possible to ensure they receive all communications and updates from AFM in time and avoid delays in reporting.

    Non-EU fund managers reporting to AFM should also note that, from 2024, they will become subject to the “Data Quality Engagement Framework”. This will mean that the AFM and European Securities and Markets Authority (“ESMA”) will periodically review the data quality of submitted reports, and may request managers to correct and resubmit reports in cases of poor data quality.

    Authored by Anna Maleva-Otto and David Soerensen.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2023 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

     

    In depth
    Authors
    More insights

  • California Privacy Rights Act Takes Effect…Sort Of

    California Privacy Rights Act Takes Effect…Sort Of

    ARTICLE / CLIENT ALERT

    California Privacy Rights Act Takes Effect…Sort Of

    January 4, 2023

    Read time: 4 min

    Key takeaways
    Overview

    On January 1, 2023, the substantive provisions of the California Privacy Rights Act (CPRA) took effect, significantly amending the California Consumer Privacy Act (CCPA) and marking another milestone in the development of US privacy law. However, an often-overlooked provision in the CPRA delays enforcement until July 1, 2023, giving businesses some breathing room as they work to refine their compliance programs and avoid costly enforcement actions.

    In depth

    The provision, buried in the CPRA’s section on agency rulemaking, reads as follows: “Notwithstanding any other law, civil and administrative enforcement of the provisions of law added or amended by this Act shall not commence until July 1, 2023, and shall only apply to violations occurring on or after that date.”[1]

    Not only does this provision delay CPRA enforcement until July 1, but it also makes clear that regulators will not be able to look back to pre-July conduct for enforcement of anything added or amended by the CPRA. As a result, businesses can find some relief in knowing they will not be on the receiving end of CPRA enforcement for conduct occurring prior to July 1, 2023—at least as it relates to obligations that are new or different under the CPRA.

    Despite this enforcement delay, the CPRA’s substantive requirements are now operative law. We’ll leave what it means for something to be “law” while being unenforceable to the philosophers, but what is clear is that businesses are now subject to complex new requirements, including new consumer rights around targeted advertising and “sensitive personal information,” and vendor contracting changes. Not to mention, businesses continue to wait for the publication of final CPRA regulations, which are now more than seven months overdue.

    Businesses that have not yet finalized their compliance programs to account for the new CPRA requirements should redouble these efforts in advance of the July 1 enforcement deadline. In particular, if your business has not completed a “data map”—an inventory of the categories, purposes and other details of your data processing activities so you can determine what requirements apply—the new year presents an opportunity to refocus on this important compliance step and obtain the necessary input and investment from stakeholders across your organization.

    After July 1, 2023, penalties for noncompliance with the CPRA could be significant: up to $2,500 per violation ($7,500 for violations that are intentional or involve children), with each impacted consumer potentially giving rise to a separate “violation.” These penalties can be levied with or without a cure period. The CPRA eliminated the 30-day cure period that was available under the CCPA and instead grants both the California Attorney General and the California Privacy Protection Agency (CPPA) discretion on whether to offer a cure period, permitting the CPPA to consider the organization’s lack of intent to violate the law and any voluntary efforts to cure the alleged violation. Therefore, good faith efforts to comply could go a long way in mitigating enforcement risk under the amended law.

    Businesses should keep in mind that the CCPA, which took effect in 2020, remains fully enforceable—and now extends to new data types because of the expiration of exemptions covering business contact and employee data.

    You can find our video series summarizing the requirements under the CCPA, CPRA and other new US state laws here. Notably, the Virginia Consumer Data Protection Act also took effect and became enforceable on January 1, 2023, creating additional compliance hurdles for covered businesses that do not exactly mirror the requirements in the CCPA/CPRA.

    We expect 2023 will be another busy year for state privacy law, and it all begins with ensuring compliance with the amended CCPA requirements.

    Authors

    Amy C. Pimentel

    Partner

    Boston

    David P. Saunders

    Partner

    Chicago

    More insights

  • Pandemic Response Accountability Committee Report Highlights Telehealth Program Integrity Concerns

    Pandemic Response Accountability Committee Report Highlights Telehealth Program Integrity Concerns

    ARTICLE / CLIENT ALERT

    Pandemic Response Accountability Committee Report Highlights Telehealth Program Integrity Concerns

    January 3, 2023

    Read time: 7 min

    Key takeaways
    Overview

    On December 1, 2022, the Pandemic Response Accountability Committee (PRAC) Health Care Subgroup issued its report on fraud, waste and abuse risks that arose as a result of the dramatic increase in telehealth services provided during the COVID-19 pandemic. The PRAC was created under the CARES Act to oversee the historic spending that was part of the federal government’s response to the COVID-19 pandemic. The PRAC Health Care Subgroup comprises the offices of the inspector general (OIGs) for six federal agencies:

    • The US Department of Health and Human Services (HHS)
    • The US Department of Defense (DoD)
    • The Office of Personnel Management (OPM)
    • The US Department of Veterans Affairs (VA)
    • The US Department of Labor (DOL)
    • The US Department of Justice (DOJ).

    Each OIG oversees an agency that administers a federal program connected to using or paying for telehealth services.

    The report highlights the increased access to services that telehealth facilitated during the pandemic and notes key focus areas with respect to program integrity and preventing fraud and abuse. The report is a resource intended to be used by stakeholders across the healthcare industry, including congressional lawmakers, federal and state agencies, and healthcare organizations. The report aims to raise awareness of the importance of safeguarding expanded telehealth services against fraud, waste and abuse.

    In depth

    Program Integrity Risks

    The OIGs identified several program integrity risks in the report, including concerns about billing practices and medical necessity. While the report focuses on telehealth services, the OIGs reminded providers that program integrity risks are prevalent in in-person services as well.

    • Upcoding: The HHS, OPM and DOL OIGs identified providers that billed at the highest possible level for a significant proportion of the total telehealth services they billed. The HHS OIG specifically identified more than 300 Medicare providers who billed for the highest, most expensive level on each claim submitted for payment, totaling approximately $5.2 million.
    • Duplicate Claims: The OIGs also identified concerns about providers billing multiple payors for the same service. The report notes that such billing may indicate that providers are intentionally submitting duplicate claims to increase payments. Intentionally submitting false or fraudulent claims to the government raises heightened fraud and abuse concerns and may expose providers to criminal liability in the context of kickback schemes. HHS identified 138 providers that repeatedly billed both traditional Medicare fee-for-service and Medicare Advantage. The VA and DoD OIGs also identified duplicate claims as risks.
    • High-Volume Billing: The HHS, OPM and VA OIGs each identified instances of providers billing for telehealth services at an “unusually high” number of hours per visit per day. The HHS OIG identified 86 providers who billed for a high number of hours of telehealth services per visit. The OIGs also identified providers who billed telehealth services for an unusually high number of individuals.
    • Inappropriate or Ineligible Services: The report cites many examples of inappropriate billing, including providers who billed for both telehealth services and facility fees (indicating that the patient was in the same location as the provider during the telehealth visit), a provider who billed for wound debridement via telehealth (which requires in-person services to remove skin from a wound) and a provider who submitted a telehealth claim for anesthesia services. The report flagged these examples as concerning because they may indicate that providers are billing for services that either are not provided appropriately or are never performed at all, in order to maximize payments for each telehealth visit.
    • Durable Medical Equipment and Lab Tests: The report cross-references prior telefraud investigations in the delivery of lab services and ordering of durable medical equipment (DME), including kickback schemes. Independent of the prior investigations and in connection with an evaluation, the HHS OIG identified 67 providers that ordered DME for a “large portion” of their Medicare patients after billing for telehealth services. According to the HHS OIG, such activity raised concerns of an underlying kickback scheme with DME suppliers to order DME after billing for telehealth services, regardless of whether the patient was ever contacted.

    Existing and Proposed Safeguards to Protect Program Integrity

    Each of the OIGs contributing to the report identified existing program integrity measures and protocols within agencies’ toolkits to address fraud and abuse concerns, including data analysis, claims edits, medical reviews and audits. These tools are often used in both the telehealth and in-person contexts, and they underscore the interdependent relationships of the agencies and OIGs in addressing potential fraud, waste and abuse in federal healthcare programs. Data analysis is used to identify key billing patterns and can identify outliers that may warrant further scrutiny or enforcement action. Claims edits, post-payment reviews and audits are all used to ensure that program requirements are met, billed and paid appropriately.

    Specific to telehealth services, the OIGs recommended the following additional program integrity measures to enhance their existing toolkits.

    • Additional and Ongoing Monitoring: Recognizing that some telehealth monitoring already exists, the OIGs suggested creating further data analysis measures focusing on program integrity risks. The HHS OIG suggested that Medicare could closely monitor telehealth services to identify providers that pose a risk to the program based on their billing habits and conduct targeted reviews of such providers. The Centers for Medicare and Medicaid Services could then use these reviews to pursue overpayment recoveries, identify pre-payment reviews and conduct fraud investigations of other claims issues.
    • Additional Billing Controls: The report suggests that the federal healthcare programs could add billing controls, such as pre-payment edits, to make sure inappropriate payments for telehealth are not issued.
    • Provider Education: The report recommends that each federal healthcare program provide more education to both providers and patients. Such education tools could help providers understand how to properly bill for telehealth services, and help individuals be aware of telehealth policies and how to report suspicious billing concerns.
    • Further Data Collection and Analysis: The report highlights several areas where the OIGs believe additional data points are necessary to properly guard against fraud, waste and abuse. For example, the HHS OIG recommended collecting data for audio-only telehealth visits and data on services that are billed “incident to,” with the goal of improving oversight and understanding how services are being provided.
    • Quality of Care Data: The report notes a dearth of information on how telehealth services impact the quality of care received by patients.

    Key Recommendations

    • Evaluate Billing and Coding Training and Compliance Programs: The OIGs note that providers should accurately bill for only the services performed and make sure such services are compatible with a telehealth environment. They suggest that this may require additional training and education for billing staff, and routine updates and tracking of enforcement activity to ensure that providers submitting claims are aware of the latest areas of focus by regulators.
    • Perform Routine Internal Audits: The OIGs recommend that providers and staff who handle billing and claims submission on their behalf perform routine internal audits to monitor for billing compliance, including efforts to detect upcoding, medical necessity issues and other areas where enhanced documentation efforts may be necessary to ensure that patient medical records match the services being billed to payors.
    • Monitor Updates and Changes to Telehealth Policies: The OIGs noted that telehealth providers should monitor changes, waivers and flexibilities made to policies for the provision and billing of telehealth services. Certain policies recently were extended as part of the Consolidated Appropriations Act (CAA), 2023, including extension of Medicare’s telehealth flexibilities until 2024 regardless of public health emergency status. The CAA 2023 also extended the safe harbor for high-deductible health plans to cover telehealth services until December 31, 2024. For an in-depth discussion of the CAA 2023’s telehealth policy provisions, click here.

    The PRAC report reflects a continued focus on program integrity and telehealth. Policymakers and regulators may use the report to identify areas that should be regulated or further scrutinized when determining the future of telehealth policy.

    Further reading:

    Authors

    James A. Cannatti III

    Partner

    Washington, DC

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Dexter Golinghorst

    Associate

    Chicago

    More insights

  • The New California Privacy Rights Act: Key Takeaways for Private Fund Managers

    The New California Privacy Rights Act: Key Takeaways for Private Fund Managers

    ARTICLE / CLIENT ALERT

    The New California Privacy Rights Act: Key Takeaways for Private Fund Managers

    December 29, 2022

    Read time: 7 min

    Key takeaways
    Overview

    On Jan. 1, 2023, the operative provisions of the California Privacy Rights Act (“CPRA”) go into effect with enforcement scheduled to begin on July 1, 2023, for violations on or after July 1, 2023.[1] Because the CPRA is more expansive in application than the California Consumer Privacy Act (“CCPA”) that it amends, more private fund managers and more data are in scope. Additionally, certain moratoriums that applied to the CCPA are also set to expire on Jan. 1. Thus, private fund managers that previously were not subject to the CCPA should consider whether they now must comply with the CCPA and the CPRA, and private fund managers already subject to the CCPA will have to make updates, including to privacy notices for California residents. For many private fund managers that are in scope of the CPRA, the compliance burden is likely to be relatively limited.

    The CPRA Applies to Any Business With Sufficient Connection to California, Including Private Fund Managers

    The law applies to any business (regardless of whether it is located in California) that had at least $25 million in gross annual revenue in the preceding calendar year (even if such revenue has no nexus to California)[2] and that collects personal information from California “consumers.” In the private fund context, “consumer” includes a prospective investor, service provider, employee, job applicant or independent contractor. “Gross annual revenue” is not defined but, in the absence of guidance, could be interpreted broadly in the private fund context. Entities that share “common branding” and share personal information will be subject to the CPRA’s requirements if any one of them meets the requirements.[3]

    Expanded Scope of the CPRA

    One key difference is that the California legislature has not extended the business-to-business (“B2B”) moratorium that up until now has applied to the CCPA. The moratorium had the effect of only applying the CCPA to California residents acting in their personal capacity as opposed to those acting on behalf of an entity. As a practical matter, the lack of a B2B moratorium expands the scope of the CCPA as of Jan. 1 and also the CPRA for private fund managers. For example, as a result of the B2B moratorium, many private fund managers were only in scope if they had prospective natural person investors in California. However, the CCPA and the CPRA now also will reach prospective institutional investors if the investors have California employees or agents from whom the private fund manager collects personal information. For example, private fund managers who have the personal phone number of a California representative of a prospect pension plan investor would be in scope. It similarly encompasses service providers that have California employees from whom the private fund manager collects personal information.

    As before, California employees, independent contractors and job applicants are still in scope and, because of the expiration of an employment-related moratorium, now will get the full rights afforded to other California residents. Previously, they had more limited rights than California residents in other contexts. As a practical matter, this means that California employees, independent contractors and job applicants should now get the same disclosures as other California residents.

    Similar to the CCPA, the CPRA exempts any information that is “subject to” the Gramm-Leach Bliley Act (“GLBA”) or Regulation S-P. This GLBA exemption effectively covers all information that fund managers collect about their existing investors, including information collected at the onboarding stage. For example, name, contact information, social security or other tax identification number and bank routing information collected in the context of a subscription agreement is covered by the GLBA and therefore CPRA-exempt. However, because Regulation S-P does not reach information collected about prospective investors prior to onboarding, such information will be subject to the CPRA. Further, the GLBA exemption does not apply to other personal information collected by private fund managers that is not covered by GLBA (e.g., employee information).[4]

    Compliance With the CPRA

    Although the CPRA’s provisions are unlikely to impose significantly higher compliance burdens on private fund managers already subject to the CCPA, there are a few recommended steps to ensure compliance with the CPRA:

    • Inventory Data Collected from Prospective Investors, Employees, Job Applicants and Business Contacts in California: Given the CPRA’s expanded reach, firms should take stock of California residents from whom they collect personal information and the nature of the information collected – particularly now that personal information from California representatives of prospective institutional investors and service providers is in scope.[5]
    • Update Website Privacy Notices: Firms should update the privacy notices on their websites, if they have a website, to ensure that they appropriately describe the businesses’ collection, use and sharing of personal information. CPRA privacy notices should include information regarding the CPRA’s new and expanded consumer privacy rights as well as any collection or use of “sensitive personal information.” Firms should ensure that the language in their notices describing the collection and use of personal information is “straightforward” and “easy to understand.”[6] Like the CCPA, the CPRA requires that these policies be updated at least once every 12 months.
    • Disclosures at the “Point of Collection” of Personal Information: In addition to website disclosures, private fund managers must also make disclosures at or before the “point of collection” of the personal information. “Point of collection” is still not defined in the CPRA. Many private fund managers satisfy this requirement by including a link in their email footers to the website notice given email is generally an early point of contact with California residents. Note that including California privacy notices in subscription documents or with the distribution of other annual privacy notices does not satisfy the CPRA’s disclosure requirements.
    • Re-Visit Third-Party, Service Provider and Contractor Agreements: The CPRA will require that businesses have written agreements in place with any services providers to which they disclose personal information or any third parties to which they sell personal information.[7] Private fund managers should review and amend applicable agreements to ensure compliance with the CPRA’s outlined obligations. For the time being, private fund managers should also consider reserving the right to make further amendments to these agreements based on the CPRA’s implementing regulations, which have not yet been finalized.

    CPRA Considerations for Alternative Data Diligence

    Private fund managers that use alternative data for investment research will want to confirm during due diligence of alternative data providers that the collection of any personal information from California residents by the vendor or any downstream supplier complies with the CPRA. Further, even though
    “de-identified information”[8] and “aggregate consumer information”[9] are excluded from the definition of “personal information” under the CPRA,[10] private fund managers will want to ensure that the data sets they receive meet the CPRA’s requirement that the de-identification/aggregation cannot be readily reverse-engineered.

    The CPRA’s more robust exception for “publicly available” information should be welcome news for web scrapers. Under the CCPA, “publicly available” was limited to information made available from federal, state or local government records. Thus, for example, when scraping the public portions of social media sites, personal information of California residents was in scope of the CCPA even where the California resident had chosen to make such information public.[11] The CPRA, however, addresses some of the anomalous results this caused by expanding the exclusion for “publicly available” information to include information that a business has a reasonable basis to believe is lawfully made available to the general public by the consumer or from widely distributed media or information made available by a person to whom the consumer has disclosed the information if the consumer has not restricted the information to a specific audience.[12]

    Authored by Alexander M. Kim, Kelly Koscuiszka, Philip J. Bezanson, Steven M. Appel, Angela Garcia, and Marissa Volpe.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.

    In depth
    Authors

    Kelly Koscuiszka

    Partner

    New York – 919 Third Avenue

    More insights

  • Welcome (But Last Minute) Relief for Prescription Drug Reporting Originally Due December 27

    Welcome (But Last Minute) Relief for Prescription Drug Reporting Originally Due December 27

    ARTICLE / CLIENT ALERT

    Welcome (But Last Minute) Relief for Prescription Drug Reporting Originally Due December 27

    December 28, 2022

    Read time: 4 min

    Key takeaways
    Overview

    Section 204 of Title II of Division BB of the Consolidated Appropriations Act, 2021 amended the Internal Revenue Code, the Employee Retirement Income Security Act of 1974 and the Public Health Service Act to add rules governing prescription drug data collection (RxDC). The rules require group health plans, including plans offered to Federal Employees Health Benefits carriers, and health insurance issuers to report certain information related to prescription drug and other healthcare expenditures to the US Departments of Labor, Health and Human Services and the Treasury (collectively, the Departments). Under the statute, the first RxDC reports were due to be filed by December 27, 2021. However, in response to concerns expressed by stakeholders, enforcement was pushed back a full year to December 27, 2022.

    In depth

    In an FAQ issued December 23, 2022 (FAQ About Affordable Care Act and Consolidated Appropriations Act, 2021 Implementation Part 56), the Departments provided relief to group health plans and health insurance issuers who are required to report information relating to prescription drug and healthcare spending.

    According to the FAQ, “plans and issuers may encounter significant operational challenges” in complying with the RxDC requirements. The FAQ further recognizes that the need to coordinate submission of a plan or issuer’s data across multiple reporting entities—and to accurately classify, compile and validate the required data—will likely result in “errors or other issues [ ] despite good faith efforts by plans and issuers.” The FAQ advises that the Departments will not take enforcement action against any plan or issuer that makes a good faith effort to comply and establishes a submission grace period through January 31, 2023.

    The FAQ also provides further “clarifications” to the RxDC rules, including:

    • Multiple Submissions by the Same Reporting Entity Is Allowed. To prevent unnecessary duplication, the RxDC rules generally bar multiple submissions of the same data file. However, the FAQ waives this requirement. Reporting entities may now create more than one submission for the year, instead of including the data of all clients within a single set of plan lists and data files for the year.
    • Submissions by Multiple Reporting Entities Is Allowed. More than one reporting entity may submit the same data file type on behalf of the same plan or issuer, instead of working together to consolidate all of the plan or issuer’s data into a single data file for each type of data.
    • Aggregation Restriction Is Suspended. The RxDC rules require that reporting entities submitting the required data on behalf of one or more plans or issuers must be aggregated to at least the aggregation level used by the reporting entity that submits data on the total annual spending on healthcare services on behalf of those plans or issuers. This requirement is waived for 2020 and 2021 data only.
    • Submission of Premium and Life-Years Data by Email Is Available for Certain Group Health Plans. Email submissions are permitted where the reporting entity is only submitting plan lists, premium and life-years data and the narrative response (if no other data is submitted).
    • Reporting on Vaccines Is Optional. Reporting entities may—but are not required to—incorporate certain vaccines in their data files.
    • Reporting Amounts Not Applied to the Deductible or Out-of-Pocket Maximum Are Optional. Reporting entities do not have to report a value for “Amounts not applied to the deductible or out-of-pocket maximum” and the “Rx Amounts not applied to the deductible or out-of-pocket maximum.”

    The relief provided by the FAQ is limited. The RxDC rules require the collection and organization of voluminous amounts of data from disparate sources and for different purposes, and reporting sometimes requires a heretofore unheard-of level of vendor-to-vendor cooperation. While a longer good faith compliance period might be more helpful particularly for group health plan sponsors, the FAQ is still very much welcome.

    Authors
    More insights

  • Omnibus Bill Extends Medicare Telehealth Flexibilities and HDHP Telehealth Safe Harbor

    Omnibus Bill Extends Medicare Telehealth Flexibilities and HDHP Telehealth Safe Harbor

    ARTICLE / CLIENT ALERT

    Omnibus Bill Extends Medicare Telehealth Flexibilities and HDHP Telehealth Safe Harbor

    December 23, 2022

    Read time: 7 min

    Key takeaways
    Overview

    On December 23, 2022, US Congress approved a year-end omnibus legislative package, Consolidated Appropriations Act, 2023 (CAA 2023), which consists of all 12 fiscal year 2023 appropriations bills and numerous other provisions, including health policy changes. The healthcare provisions in this omnibus package extend key Medicare telehealth flexibilities and the temporary telehealth safe harbor for High Deductible Health Plans (HDHP) first-dollar coverage. The passing of the omnibus package presents a victory for industry advocates that have sought to extend the COVID-19 Medicare flexibilities and the HDHP safe harbor. The Medicare provisions will continue the flexibilities for providers and, coupled with the HDHP safe harbor, will enable beneficiaries to access expanded healthcare options through telehealth services. However, as the COVID-19 flexibilities and HDHP safe harbor are extended on a temporary basis through December 31, 2024, stakeholders will need to continue to engage with Congress on a more permanent solution.

    In depth

    On December 23, 2022, the US Congress approved a year-end omnibus legislative package, Consolidated Appropriations Act, 2023 (CAA 2023), which consists of all 12 fiscal year 2023 appropriations bills and numerous other provisions, including health policy changes. The healthcare provisions in this omnibus package extend key Medicare telehealth flexibilities and the temporary telehealth safe harbor for High Deductible Health Plans (HDHP) first-dollar coverage.

    EXTENSION OF MEDICARE FLEXIBILITIES UNDER THE OMNIBUS BILL

    Historically, Medicare has provided coverage for telehealth services in instances where patients would otherwise be geographically distant from approved providers (e.g., physicians, nurse practitioners and clinical psychologists). Section 1834(m) of the Social Security Act provides that telehealth services are covered if the beneficiary is seen: (1) at an approved “originating site” (e.g., physician office, hospital or skilled nursing facility) that is located within a rural Health Professional Shortage Area that is either outside of a Metropolitan Statistical Area (MSA), in a rural census tract or in a county outside of an MSA; (2) by an approved provider; (3) for a defined set of services, including consultations, office visits, pharmacological management and individual and group diabetes self-management training services; and (4) using certain telecommunications technologies.

    As part of the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 and the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), the US Secretary of the Department of Health and Human Services (HHS Secretary) was given authority to waive certain Medicare restrictions regarding coverage and payment for telehealth services during the COVID-19 Public Health Emergency (PHE). Through delegated authority from the HHS Secretary, the Centers for Medicare & Medicaid Services implemented a temporary expansion of Medicare coverage and payment for telehealth services. This, in turn, increased access to care for Medicare beneficiaries while reducing the risk of exposure to COVID-19. While originally initiated in response to the pandemic, these flexibilities have proven beneficial for patients and providers, and stakeholders have advocated that they remain in place beyond the end of the PHE. Congress did take steps through the Consolidated Appropriations Act, 2022 (CA 2022), which passed in March 2022, to extend these flexibilities (albeit temporarily) for 151 days after the end of the PHE.

    The PHE remains in effect at least through January 2023 and is expected be extended at least one more time per the promised 60-day notification from the Biden administration. However, stakeholders remain concerned about the potential termination of these flexibilities when the PHE ends and the instability it will cause for patients and providers. Congress has again acted to provide a longer extension and has officially untied the flexibilities from the existence of the PHE. CAA 2023 continues the Medicare telehealth flexibilities for two calendar years, regardless of the status of the PHE, through December 31, 2024. These include:

    • Waiving the geographic restrictions and originating site requirements (Sec. 4113(a))
    • Expanding the list of practitioners eligible to furnish telehealth services (Sec. 4113(b))
    • Allowing telehealth services for Rural Health Clinics and Federally Qualified Health Centers (Sec. 4113(c))
    • Delaying the in-person visit requirement before a patient receives mental health services furnished through telehealth and telecommunications (Sec. 4113(d))
    • Allowing for telehealth services through audio-only telecommunications (Sec. 4113(e))
    • Allowing for telehealth to be used for a required face-to-face encounter prior to the recertification of a patient’s eligibility for hospice care (Sec. 4113(f)).

    EXTENSION OF THE SAFE HARBOR FOR HDHPS TO COVER TELEHEALTH SERVICES

    In addition to creating telehealth flexibilities under Medicare, the CARES Act established a temporary safe harbor that permitted HDHPs to cover telehealth and remote care services on a first-dollar basis without jeopardizing Health Savings Account (HSA) contributions. By providing HDHP participants coverage for telehealth services without requiring them to first meet the minimum required deductible, the safe harbor increased access to telehealth services. Additionally, covered individuals who received these services were still able to contribute to their HSAs because telehealth services were temporarily disregarded for purposes of HSA eligibility in determining whether an individual can make an HSA contribution.

    The original safe harbor applied to plan years beginning on or before December 31, 2021, and was set to expire at the end of 2021. In March 2022, Congress extended the safe harbor until December 31, 2022, through the CAA 2022, providing the same telehealth protections for HDHPs between April 1, 2022, and December 31, 2022. Although many expected the extension to be retroactive, the CAA 2022 created a gap in the safe harbor application. Between January 1, 2022, and March 31, 2022, HDHPs could not provide telehealth services to participants who had not yet satisfied their minimum deductible ($1,400 for individuals and $2,800 for families in 2022) without providing disqualifying coverage for HSA contributions. Further, the bill adjusted the original CARES Act language and limited the safe harbor until December 31, 2022, regardless of when the plan year started.

    Through Section 4151 of the CAA 2023, Congress has extended the safe harbor period again, now through December 31, 2024. This extension will allow HDHPs with plan years beginning after December 31, 2022, and before January 1, 2025, to rely on the safe harbor and continue coverage of telehealth services without constituting disqualifying coverage for HSA contributions. Unlike the previous extension, this extension does not create a gap in the safe harbor. Therefore, HDHPs can continue to cover telehealth services on a first-dollar basis without disqualifying HDHP participants from making HSA contributions.

    While CAA 2023 would resolve many of the open Medicare coverage questions for telehealth providers (at least for the next two years), it does not address any waivers for controlled substance prescribing, which may leave telehealth providers without a clear, compliant path to continuing to treat patients virtually.

    KEY TAKEAWAYS

    The passing of the omnibus package presents a victory for industry advocates that have sought to extend the COVID-19 Medicare flexibilities and the HDHP safe harbor. The Medicare provisions will continue the flexibilities for providers and, coupled with the HDHP safe harbor, will enable beneficiaries to access expanded healthcare options through telehealth services. However, as the COVID-19 flexibilities and HDHP safe harbor are extended on a temporary basis through December 31, 2024, stakeholders will need to continue to engage with Congress on a more permanent solution.

    Authors

    Amanda Enyeart

    Partner

    Chicago

    Marshall E. Jackson , Jr.

    Partner

    Washington, DC

    Lisa Mazur

    Partner

    Chicago

    Grayson I. Dimick

    Associate

    Washington, DC

    Jayda Greco

    Partner

    Chicago

    Sarah G. Raaii

    Partner

    Chicago

    More insights

  • Back to the Drawing Board: CMS Proposes Changing the Overpayment Rule’s “Identified” Definition

    ARTICLE / CLIENT ALERT

    Back to the Drawing Board: CMS Proposes Changing the Overpayment Rule’s “Identified” Definition

    December 22, 2022

    Read time: 5 min

    Key takeaways
    Overview

    In December 2022, the Center for Medicare and Medicaid Services (CMS) unexpectedly issued a proposed rule that would materially change the obligations of entities participating in the Medicare program to report and return overpayments of Medicare Part A and Part B funds. The proposed rule would revert to the definition of “identified” that CMS originally proposed in 2012 and removes the concept of quantification of the overpayment serving as the start of the 60-day clock.

    In depth

    Rather than allow Part A and Part B providers and suppliers time to conduct “reasonable diligence” before determining that an overpayment has occurred and to quantify the amount of the overpayment, as set forth in the current overpayment refund rule at 42 C.F.R. § 401.305, the new proposed rule would require that Part A and Part B overpayments be reported and returned within 60 days of the provider or supplier having actual knowledge, or being in reckless disregard or deliberate ignorance, of the existence of the overpayment. Under the current rule, providers and suppliers that become aware that a potential overpayment may have occurred are expected to investigate the existence of the overpayment and determine the amount before notifying the government and returning the overpaid amounts. Only after the quantification of the overpayment does the 60-day clock begin to run on returning the overpayment to the government.

    The proposed rule would remove the following language at 42 C.F.R. § 401.305(a)(2):

    • A person has identified an overpayment when the person has, or should have through the exercise of reasonable diligence, determined that the person has received an overpayment and quantified the amount of the overpayment. A person should have determined that the person received an overpayment and quantified the amount of the overpayment if the person fails to exercise reasonable diligence and the person in fact received an overpayment.

    This language would be replaced with the new proposed 42 C.F.R. § 401.305(a)(2):

    • A person has identified an overpayment when the person knowingly receives or retains an overpayment. The term “knowingly” has the meaning set forth in 31 U.S.C. 3729(b)(1)(A).

    “Knowingly” as defined at 31 U.S.C. 3729(b)(1)(A) means “that a person, with respect to information—(i) has actual knowledge of the information; (ii) acts in deliberate ignorance of the truth or falsity of the information; or (iii) acts in reckless disregard of the truth or falsity of the information.”

    Even though this very similar to the proposed definition as in the original rulemaking, CMS does not address the inherent ambiguities and practical problems presented by the proposed definition. For example, the proposed rule does not explain how a provider or supplier would return an overpayment within 60 days if the existence of the overpayment is known but the amount of the overpayment remains unknown. It is not uncommon for it to take several months, if not more, for a provider or supplier to determine the amount of an overpayment. CMS recognized this fact in the preamble to the current rule, but is silent on this issue in the new proposed rule. CMS also does not explain what it means to be in “reckless disregard or deliberate ignorance” that the provider or supplier received or retained an overpayment.

    The proposed change appears to be the result of litigation surrounding the Medicare Part C and D overpayment rule (UnitedHealthcare Ins. Co. v. Azar, 330 F. Supp. 3d 173, 191 (D.D.C. 2018), rev’d in part on other grounds sub nom. UnitedHealthcare Ins. Co. v. Becerra, 16 F.4th 867 (D.C. Cir. 2021), cert. denied, 142 S. Ct. 2851 (U.S. June 21, 2022) (No. 21-1140)), in which a federal court determined that CMS’s incorporation of “reasonable diligence” to investigate an overpayment in the Part C and D rule was outside of the agency’s rulemaking authority under the overpayment statute. However, the cited case concerned whether CMS could impose obligations of Part C plans to conduct investigations into potential overpayments, and did not address limiting the time period necessary to quantify the amount of an overpayment to 60 days. It is possible that CMS intends for the proposed rule to be interpreted to incorporate the quantification of the overpayment amount into the knowledge requirement, but such an interpretation is not articulated in the preamble. As the proposed rule is currently drafted, providers and suppliers could be put in a position of incurring reverse False Claims Act liability risk for overpayments that are known to exist but cannot be quantified within 60 days. Providers and suppliers may also risk being accused of having constructive knowledge that an overpayment was received or retained without any guidance as to what that means.

    The proposed rule was inserted into a regulatory package issued on December 14, 2022, to be published in the Federal Register on December 27, 2022. The package primarily addressed issues (such as overpayment refunds) that are relevant to Medicare Part D sponsors and Medicare Advantage contractors, but that would not typically be relevant to Part A and Part B entities. Public comments on the proposed rule are due by February 13, 2023. We will issue future publications on the proposed rule in 2023 and encourage stakeholders to seriously consider providing comments given the operational challenges and potentially significant liability created by the proposed rule.

    Authors

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Monica Wallace

    Partner

    Chicago

    More insights

  • Nasdaq Changes Compliance Deadlines for Board Diversity Rules

    Nasdaq Changes Compliance Deadlines for Board Diversity Rules

    ARTICLE / CLIENT ALERT

    Nasdaq Changes Compliance Deadlines for Board Diversity Rules

    December 22, 2022

    Read time: 4 min

    Key takeaways
    Overview

    On August 6, 2021, the US Securities and Exchange Commission (SEC) approved the listing rules proposed by The Nasdaq Stock Market LLC (Nasdaq) to advance board diversity and enhance the transparency of diversity statistics (Board Diversity Rule). Nasdaq’s Board Diversity Rule phases in the new requirements over a five-year period, from 2022 to 2026.

    On December 12, 2022, Nasdaq filed a proposed rule change with the SEC to modify the compliance deadline for its board diversity requirements. The SEC declared the proposed rule change effective as of December 14, 2022. If adopted, the proposed rule change will extend and simplify the compliance deadline for all Nasdaq-listed public companies.

    The compliance deadlines were previously tied to the date of the SEC’s August 6, 2021, approval of the Board Diversity Rule. Nasdaq’s proposed rule change adopts a fiscal year-end compliance deadline both for the Board Diversity Rule’s disclosure requirements and for its board diversity requirements that remain to be phased in through 2026.

    In depth

    NEW COMPLIANCE DEADLINES FOR THE BOARD DIVERSITY REQUIREMENTS

    The proposed rule change pushes the deadline for listed companies from August 6 of the applicable year during the phase-in period to December 31 of the same year. Accordingly, the new compliance deadlines are as follows:

    • Companies listed on the Nasdaq Global Select Market and Nasdaq Global Market must have, or explain why they do not have, one diverse director (as defined in Nasdaq Rule 5605(f)(1)) by December 31, 2023, and two diverse directors by December 31, 2025. The new December 31 deadlines replace both August 6 deadlines, respectively.
    • Companies listed on the Nasdaq Capital Market must have, or explain why they do not have, one diverse director by December 31, 2023, and two diverse directors by December 31, 2026. The new December 31 deadlines replace both August 6 deadlines, respectively.

    NEW COMPLIANCE DEADLINES FOR THE DIVERSITY STATISTICS DISCLOSURE REQUIREMENTS

    • The Board Diversity Rule requires that listed companies make yearly disclosures of board diversity statistics in tabular format (Matrix disclosure). The proposed rule change pushes the annual deadline for making such disclosure to December 31.
    • It also simplifies compliance for companies that wish to post their Matrix disclosure on their website by allowing them to satisfy the Nasdaq notice requirement by submitting a URL link to their Matrix disclosure via email to drivingdiversity@nasdaq.com.

    The proposed rule change has no impact on the nature of the diversity requirements or the content of the disclosures that the Board Diversity Rule calls for, set forth in detail in our client alert, “SEC approves new Nasdaq Board Diversity Disclosure Rules.” Accordingly, foreign issuers, smaller reporting companies and companies whose board does not exceed five members may continue to benefit from reduced board diversity requirements. Additionally, the proposed rule change has no impact on the application of the Board Diversity Rules to newly listed companies on Nasdaq.

    The Nasdaq Listing Center website provides a list of FAQs on the Board Diversity Rule, as well as Board Diversity Matrix templates to assist listed companies in making board diversity statistics disclosures.

    For more information, please contact your regular McDermott lawyer or one of the authors of this article. For more information about McDermott Will & Emery’s diversity, equity and inclusion efforts, please see the Firm’s 2021 Diversity, Equity & Inclusion Year in Review.

    Authors

    Thomas P. Conaghan

    Partner

    Washington, DC, New York – One Vanderbilt Avenue

    Eric Orsic

    Partner

    Chicago

    Heidi J. Steele

    Partner

    Chicago

    David A. Cifrino

    Counsel

    Boston

    More insights

  • ‘Tis the Season: Colorado Attorney General Releases New Draft CPA Regulations

    ‘Tis the Season: Colorado Attorney General Releases New Draft CPA Regulations

    ARTICLE / CLIENT ALERT

    ‘Tis the Season: Colorado Attorney General Releases New Draft CPA Regulations

    December 22, 2022

    Read time: 3 min

    Key takeaways
    Overview

    On December 21, 2022, the Colorado Attorney General (AG) released its newest set of draft regulations to the Colorado Privacy Act (CPA), which will take effect in July 2023. This latest draft includes updates to the proposed regulations issued on September 30, 2022, following a public comment period. Stakeholders now have until January 18, 2023, to submit comments on these latest draft regulations in advance of a rulemaking hearing set for February 1, 2023.

    In depth

    In soliciting additional comments to the revised CPA regulations, the Colorado AG is seeking specific input on: (1) clarifications to definitions; (2) use of IP addresses to verify consumer requests; (3) a universal opt-out mechanism; (4) streamlining the privacy policy requirements while maintaining their comprehensiveness; and (5) bona fide loyalty programs. The latest draft regulations include detailed questions from the AG to stakeholders on each of these topics.

    There seems to be something for everyone in the latest updates to the CPA regulations. Some changes will be heralded by privacy advocates, while others will make implementation easier for businesses. While we cannot document each of the many updates here, some of the more notable revisions include:

    The public comment period on the latest draft regulations is open through January 18, 2023. There will then be a public rulemaking hearing on February 1, 2023. From there, we anticipate the Colorado AG will make final changes to the regulations before ultimately publishing them in advance of the July 1, 2023, effective date of the CPA.

    Although the proposed Colorado regulations will not take effect until July 2023, many companies are working now to update their existing programs for CCPA compliance and may want to consider incorporating some of the key Colorado components as they do.

    can help you integrate the Colorado requirements into your program, notices and processes. We can also help businesses submit comments to the new proposed regulations. For assistance, please contact your regular MDermott Will & Emery lawyer or the authors of this article.

    Authors

    David P. Saunders

    Partner

    Chicago

    Amy C. Pimentel

    Partner

    Boston

    More insights

  • End-of-Year Employment Law Developments

    End-of-Year Employment Law Developments

    ARTICLE / CLIENT ALERT

    End-of-Year Employment Law Developments

    December 22, 2022

    Read time: 5 min

    Key takeaways
    Overview

    Federal Same Sex Marriage Act Becomes Law

    On Dec. 13, 2022, President Joe Biden signed into law the Respect for Marriage Act, which mandates federal recognition of same-sex marriages. The law also prohibits states from refusing to recognize out-of-state marriages on the basis of sex, race, ethnicity or national origin. In addition, the statute officially voids the Defense of Marriage Act, which defined marriage as only between a man and a woman.

    Biden Signs “Speak Out Act”

    On Dec. 7, 2022, the Speak Out Act (“SOA”) was signed into law by President Biden to address agreements entered into by employers. With respect to a sexual assault or sexual harassment dispute, the SOA provides that no non-disclosure clause or non-disparagement clause agreed to before the dispute arises shall be judicially enforceable. A non-disclosure clause requires a party to a contract not to discuss the conduct, the existence of a settlement involving conduct, or information about the terms and conditions of the contract or agreement. A non-disparagement clause prohibits a party to a contract from making negative statements about another party.

    This new legislation follows the enactment of the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act, which went into effect in March 2022, to permit individuals with sexual harassment or assault claims who entered into pre-dispute arbitration agreements or pre-dispute joint-action waivers to reject those agreements.

    NLRB Decision Expands Damages for Unfair Labor Practices

    The National Labor Relations Board (“NLRB”) issued a decision on Dec. 13, 2022, that broadens the scope of make-whole remedies available against an employer for violations of the National Labor Relations Act. Such make-whole remedies now include “compensating [charging parties] for direct or foreseeable pecuniary harms resulting from [the employer’s] unfair labor practice.” Examples of these remedies cited by the NLRB include, among others:

    • Compensation for health care expenses that an employee incurs as a result of an unlawful termination of health insurance;
    • Compensation for credit card late fees incurred;
    • Compensation for loss of a home or a car that an employee suffered as a result of an unlawful discharge; and
    • Employer sponsorship of work authorizations for the firing of undocumented workers.

    New York Governor Signs Law Forbidding Retaliation for Lawful Absences

    A New York State attendance law will take effect on Feb. 19, 2023. This law prohibits employers from retaliating against workers for taking legally protected leave. It will bar employers from penalizing workers under increasingly common ‘no-fault’ attendance policies that assign points to employees for absences, regardless of the reason for the absence. Employers will be prohibited from using these points-based attendance policies, or to otherwise discriminate or retaliate against employees taking any protected leave under federal, state or local law.

    New York State Expands Workplace Protections for Nursing Employees

    An amendment to the NYS Labor Law, effective June 7, 2023, will expand the rights of nursing mothers to express breast milk in the workplace. The legislation is similar to a New York City lactation accommodation law adopted in 2019, discussed in the Alert “New York City Adopts Lactation Accommodation Law.” The new amendment requires employers to provide break time for nursing employees for three years following the birth of a child. Additionally, employers are required to designate a room, with certain minimum requirements specified in the law, to allow employees to pump breastmilk in the workplace. Employers must also develop, implement and distribute written policies regarding the rights of nursing mothers in the workplace.

    New York Governor Signs State Salary Transparency Legislation

    New York Senate Bill S9427A requiring employers with four or more employees to disclose compensation or a range of compensation, and a job description, when advertising for a new job opportunity, promotion or transfer has been signed by Governor Kathy Hochul. The legislation is similar to New York City’s salary transparency law that went into effect in November 2022. The new law will take effect on Sept. 17, 2023.

    New York State Updates to Paid Family Leave

    The New York State Workers’ Compensation Board has updated the request forms for Paid Family Leave (PFL) to remove unnecessary pronouns and include a “Gender X” option. Additionally, the forms have been updated to include siblings as permitted family members, to reflect an expansion in the New York Paid Family Leave Law, previously discussed in this Alert “New Year, New Employment and Benefits Developments for Employers,” taking effect in 2023 that will allow covered employees eligibility to use PFL to care for siblings with serious health conditions. Additionally, the new PFL policies will raise the maximum weekly benefit for 2023 and lower the annual contribution for employees.

    Authored by Mark E. Brossman, Ronald E. Richman, Martin L. Schmelkin, Scott A. Gold, Max Garfield and Donna K. Lazarus.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2022 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Ronald E. Richman

    Partner

    New York – 919 Third Avenue

    Martin L. Schmelkin

    Partner

    New York – 919 Third Avenue

    Max Garfield

    Partner

    New York – 919 Third Avenue

    Donna K. Lazarus

    Partner

    New York – 919 Third Avenue

    More insights